Sex differences in patients with COVID-19 after bariatric surgery: a multicenter cross-sectional study
Frontiers in Public Health · 2024
DOI: 10.3389/fpubh.2023.1293318 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Frontiers in Public Health, 2024. Verfasst von Senlin Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Obesity and Metabolic Health, Department of General Surgery, The Third People's Hospital of Chengdu, The Affiliated Hospital of Southwest …. Hauptthemen laut MEDLINE: COVID-19, Bariatric Surgery. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
This multicenter, cross-sectional study aimed to investigate whether sex differences persist among patients who have undergone bariatric surgery and tested positive for the coronavirus disease (COVID-19).
Methods
We conducted a multicenter cross-sectional study via an online electronic questionnaire to collect data. Categorical data were presented as absolute and relative frequencies. Data for continuous variables were expressed as mean and standard deviation (SD) or median [interquartile range (IQR)]. We employed ordered logistic regression to assess whether females had higher odds of an increased self-reported duration of the most severe symptom compared to males. Using a modified Poisson regression model with robust standard errors to assess the differences in clinical characteristics among COVID-19 cases.
Results
Statistical analysis revealed significant differences in the prevalence rates of various comorbidities. Among participants who reported their temperature during COVID-19 infection, more than half engaged in vitamin supplementation and regular exercise, while 4.2% remained asymptomatic. The probability of females experiencing a longer duration of severe symptoms increased compared to males [adjusted Odds Ratio (aOR) = 1.92, 95% confidence interval (CI) 1.73–2.12]. In the multivariate mixed-effects Poisson regression analysis, compared to males, females exhibited a lower prevalence rate of asymptomatic infection [adjusted prevalence ratio (aPR 0.40, 95% CI 0.28–0.58), lower prevalence of infection without therapeutic medication use (aPR 0.76, 95% CI 0.70–0.82), and lower prevalence of multiple infections (aPR 0.39, 95% CI 0.20–0.74)].
Conclusion
This cross-sectional study indicates the persistence of sex differences among patients with COVID-19 who have undergone bariatric surgery. Further research is needed to explore the underlying factors contributing to this disparity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Obesity and Metabolic Health, Department of General Surgery, The Third People's Hospital of Chengdu, The Affiliated Hospital of Southwest Jiaotong University, Chengdu, China.
- Department of General Surgery, Center for Obesity and Metabolic Health, The Third People's Hospital of Chengdu, The Affiliated Hospital of Southwest Jiaotong University, Chengdu, China.
- Mianyang Central Hospital, Mianyang, China.
- First Affiliated Hospital of Air Force Military Medical University, Xi'an, China.
- Dazhou Central Hospital, Dazhou, China.
Zitieren
APA
Wang, S., Jang, Q., Wang, H., Yang, Y., Ruan, M., Yu, J., Li, X., & Luo, D. (2024). Sex differences in patients with COVID-19 after bariatric surgery: a multicenter cross-sectional study. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2023.1293318
Vancouver
Wang S, Jang Q, Wang H, Yang Y, Ruan M, Yu J, et al. Sex differences in patients with COVID-19 after bariatric surgery: a multicenter cross-sectional study. Frontiers in Public Health. 2024. doi:10.3389/fpubh.2023.1293318
BibTeX
@article{Wang2024,
author = {Wang, Senlin and Jang, Qiubai and Wang, Han and Yang, Yunning and Ruan, Min and Yu, Juan and Li, Xiuying and Luo, Dan},
title = {Sex differences in patients with COVID-19 after bariatric surgery: a multicenter cross-sectional study},
journal = {Frontiers in Public Health},
year = {2024},
doi = {10.3389/fpubh.2023.1293318}
}
EUVIMED